Axogen Inc.. (AXGN) NASDAQ

$9.28 0.05 (0.54%)

Market Cap: $383.62M

As of 11/30/21 10:56 AM EST. Market open.

(AXGN)

Axogen Inc.. (AXGN) NASDAQ

$9.28 0.05 (0.54%)

Market Cap: $383.62M

As of 11/30/21 10:56 AM EST. Market open.

Axogen (AXGN) is the leading company focused specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. Axogen employees are passionate about helping to restore peripheral nerve function and quality of life to patients with physical damage or transection to peripheral nerves by providing innovative, clinically proven, and ... read more

Axogen (AXGN) is the leading company focused specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. Axogen employees are passionate about helping to restore peripheral nerve function and quality of life to patients with physical damage or transection to peripheral nerves by providing innovative, clinically proven, and economically effective repair solutions for surgeons and health care providers. Peripheral nerves provide the pathways for both motor and sensory signals throughout the body. Every day, people suffer traumatic injuries or undergo surgical procedures that impact the function of their peripheral nerves. Physical damage to a peripheral nerve, or the inability to properly reconnect peripheral nerves, can result in the loss of muscle or organ function, the loss of sensory feeling, or the initiation of pain. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
Full Time Employees
357
CEO Compensation (Base)
$575,000
Address
.
KEY STATS
Open
$9.28
Previous Close
$9.23
Days Range
$9.11 - $10.05
52 week range
$9.11 - $23.94
Volume
120,685
Avg. Volume (30 days)
350,043
Market Cap
$383.62M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
41,562,559
Open
$9.28
Previous Close
$9.23
Days Range
$9.11 - $10.05
52 week range
$9.11 - $23.94
Volume
120,685
Avg. Volume (30 days)
350,043
Market Cap
$383.62M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
41,562,559

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR AXOGEN INC.
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Zaderej Karen L. CEO Nov 24, 2021 Option Exercise $8.95 52,375 468,756 921,147 Nov 29, 2021, 04:09 PM
Zaderej Karen L. CEO Aug 12, 2021 Option Exercise $5.09 8,254 42,013 822,272 Aug 16, 2021, 04:10 PM
Zaderej Karen L. CEO Aug 13, 2021 Option Exercise $3.67 46,500 170,655 868,772 Aug 16, 2021, 04:10 PM
Zaderej Karen L. CEO Aug 10, 2021 Option Exercise $5.09 75,000 381,750 855,018 Aug 10, 2021, 04:52 PM
Zaderej Karen L. CEO Aug 06, 2021 Sale $18.47 41,000 757,194 840,262 Aug 10, 2021, 04:52 PM
Donovan Michael Patrick VP Operations Jul 21, 2021 Sale $20.04 1,935 38,777 40,839 Jul 23, 2021, 04:06 PM
DeVinney Erick Wayne VP Peripheral Nerve Science Jul 20, 2021 Option Exercise $19.20 392 7,526 80,426 Jul 21, 2021, 04:16 PM
Donovan Michael Patrick VP Operations Jul 20, 2021 Option Exercise $19.20 637 12,230 42,774 Jul 21, 2021, 04:15 PM
Zaderej Karen L. CEO Jul 20, 2021 Option Exercise $19.20 8,812 169,190 780,018 Jul 21, 2021, 04:15 PM
Sandberg Eric Chief Commercial Officer Jul 20, 2021 Option Exercise $19.20 1,090 20,928 6,541 Jul 21, 2021, 04:14 PM
Scopelianos Angelo Chief R&D Officer Jul 20, 2021 Option Exercise $19.20 637 12,230 10,120 Jul 21, 2021, 04:14 PM
MARIANI PETER J EVP & Chief Financial Officer Jul 20, 2021 Option Exercise $19.20 918 17,626 21,026 Jul 21, 2021, 04:14 PM
Billet Isabelle Chief Strategy and BD Officer Jul 20, 2021 Option Exercise $19.20 728 13,978 13,360 Jul 21, 2021, 04:13 PM
MARTINEZ MARIA D. Chief Human Resources Officer Jul 20, 2021 Option Exercise $19.20 637 12,230 4,867 Jul 21, 2021, 04:13 PM
Friedman Mark Louis VP Regulatory Affairs & Policy Jul 20, 2021 Option Exercise $19.20 637 12,230 16,308 Jul 21, 2021, 04:12 PM
NEELS GUIDO J Director May 19, 2021 Option Exercise $4.28 40,000 171,350 42,591 Jun 07, 2021, 05:25 PM
DeVinney Erick Wayne VP of Clin. & Trans. Sciences Apr 28, 2021 Option Exercise $2.86 10,000 28,600 78,082 Apr 30, 2021, 04:10 PM
Zaderej Karen L. CEO Apr 16, 2021 Option Exercise $5.09 100,000 509,000 765,912 Apr 20, 2021, 04:09 PM
Zaderej Karen L. CEO Mar 25, 2021 Option Exercise $3.67 34,500 126,615 665,912 Mar 29, 2021, 04:17 PM
Freitag Gregory Gene Director Feb 25, 2021 Sale $22.06 24,000 529,440 228,352 Mar 01, 2021, 04:08 PM
Donovan Michael Patrick VP Operations Feb 18, 2021 Sale $19.15 1,808 34,623 40,839 Feb 19, 2021, 04:12 PM
Scopelianos Angelo Chief R&D Officer Feb 17, 2021 Option Exercise $18.71 406 7,596 7,046 Feb 18, 2021, 05:27 PM
Friedman Mark Louis VP, Regulatory & Quality Feb 17, 2021 Option Exercise $18.70 951 17,787 13,936 Feb 18, 2021, 05:26 PM
DeVinney Erick Wayne VP, Clinical&Translational Sc Feb 17, 2021 Option Exercise $18.70 1,864 34,857 68,082 Feb 18, 2021, 05:26 PM
Sandberg Eric Chief Commercial Officer Feb 17, 2021 Option Exercise $18.70 903 16,886 3,223 Feb 18, 2021, 05:25 PM
Donovan Michael Patrick VP Operations Feb 17, 2021 Option Exercise $18.71 797 14,912 42,647 Feb 18, 2021, 05:17 PM
Freitag Gregory Gene Director Feb 17, 2021 Option Exercise $18.70 1,577 29,490 252,352 Feb 18, 2021, 05:16 PM
MARTINEZ MARIA D. Chief Human Resources Officer Feb 17, 2021 Option Exercise $18.71 406 7,596 5,584 Feb 18, 2021, 05:15 PM
MARIANI PETER J Chief Financial Officer Feb 17, 2021 Option Exercise $18.71 2,954 55,261 18,234 Feb 18, 2021, 05:15 PM
Zaderej Karen L. CEO Feb 17, 2021 Option Exercise $18.71 7,686 143,805 631,412 Feb 18, 2021, 05:15 PM
Billet Isabelle Chief Strategy and BD Officer Feb 17, 2021 Option Exercise $18.71 454 8,494 11,080 Feb 18, 2021, 05:14 PM
Donovan Michael Patrick VP Operations Feb 05, 2021 Option Exercise $19.81 5,190 102,814 40,839 Feb 09, 2021, 07:12 PM
Donovan Michael Patrick VP Operations Feb 05, 2021 Option Exercise $5.14 20,000 102,800 46,029 Feb 09, 2021, 07:12 PM
Zaderej Karen L. CEO Jan 08, 2021 Sale $20.00 65,000 1,300,000 609,099 Jan 12, 2021, 04:08 PM
Donovan Michael Patrick VP Operations Dec 30, 2020 Sale $17.48 1,733 30,293 26,029 Dec 31, 2020, 04:06 PM
DeVinney Erick Wayne VP, Clinical&Translational Sc Dec 29, 2020 Sale $17.81 371 6,608 63,240 Dec 30, 2020, 05:33 PM
Donovan Michael Patrick VP Operations Dec 29, 2020 Sale $17.81 567 10,098 27,762 Dec 30, 2020, 04:09 PM
Freitag Gregory Gene Director Dec 29, 2020 Sale $17.81 916 16,314 248,345 Dec 30, 2020, 12:53 PM
MARIANI PETER J Chief Financial Officer Dec 29, 2020 Sale $17.81 1,293 23,028 10,376 Dec 30, 2020, 11:56 AM
Scopelianos Angelo VP Research & Development Dec 29, 2020 Sale $17.81 567 10,098 5,529 Dec 30, 2020, 11:55 AM
Zaderej Karen L. CEO Dec 29, 2020 Sale $17.81 3,500 62,335 674,099 Dec 30, 2020, 11:53 AM
Friedman Mark Louis VP,Regulatory & Quality Dec 29, 2020 Sale $17.81 567 10,098 11,124 Dec 30, 2020, 11:52 AM
MARTINEZ MARIA D. Chief Human Resources Officer Dec 29, 2020 Sale $17.81 567 10,098 4,665 Dec 30, 2020, 11:51 AM
Billet Isabelle Chief Strategy and BD Officer Dec 29, 2020 Sale $17.81 649 11,559 9,496 Dec 30, 2020, 11:51 AM
Zaderej Karen L. CEO Dec 23, 2020 Option Exercise $4.81 19,375 93,194 666,094 Dec 28, 2020, 09:26 AM
Donovan Michael Patrick VP Operations Dec 22, 2020 Sale $17.19 279 4,796 26,029 Dec 23, 2020, 02:32 PM
Zaderej Karen L. CEO Dec 21, 2020 Sale $16.42 1,275 20,936 646,719 Dec 22, 2020, 05:32 PM
DeVinney Erick Wayne VP, Clinical&Translational Sc Dec 21, 2020 Sale $16.42 147 2,414 62,111 Dec 22, 2020, 03:22 PM
Freitag Gregory Gene Director Dec 21, 2020 Sale $16.42 379 6,223 245,076 Dec 22, 2020, 03:15 PM
Donovan Michael Patrick VP Operations Dec 21, 2020 Sale $16.42 96 1,576 26,308 Dec 22, 2020, 01:55 PM
MARIANI PETER J Chief Financial Officer Dec 21, 2020 Sale $16.42 481 7,898 6,419 Dec 22, 2020, 12:54 PM
Friedman Mark Louis VP,Regulatory & Quality Dec 21, 2020 Sale $16.42 96 1,576 8,893 Dec 22, 2020, 11:38 AM
DeVinney Erick Wayne VP, Clinical&Translational Sc Dec 15, 2020 Option Exercise $16.50 4,373 72,155 61,683 Dec 17, 2020, 04:41 PM
DeVinney Erick Wayne VP, Clinical&Translational Sc Dec 15, 2020 Option Exercise $4.81 15,000 72,150 66,056 Dec 17, 2020, 04:41 PM
Friedman Mark Louis VP,Regulatory & Quality Dec 03, 2020 Option Exercise $3.86 3,812 14,703 8,614 Dec 07, 2020, 02:39 PM
Donovan Michael Patrick VP Operations Nov 09, 2020 Sale $15.00 17,617 264,255 26,029 Nov 12, 2020, 10:14 AM
Zaderej Karen L. CEO Nov 09, 2020 Sale $14.53 14,000 203,420 644,869 Nov 10, 2020, 09:56 AM
MARIANI PETER J Chief Financial Officer Oct 30, 2020 Option Exercise $5.04 60,000 302,400 80,683 Nov 03, 2020, 05:11 PM
MARIANI PETER J Chief Financial Officer Oct 30, 2020 Sale $12.41 75,683 939,353 20,683 Nov 03, 2020, 05:11 PM
Freitag Gregory Gene Director Sep 15, 2020 Option Exercise $3.67 13,046 47,879 244,530 Sep 17, 2020, 04:57 PM
NEELS GUIDO J Director Sep 03, 2020 Option Exercise $11.75 2,591 30,444 2,591 Sep 08, 2020, 05:37 PM
Rudelius Robert James Director Sep 03, 2020 Option Exercise $11.75 2,591 30,444 48,183 Sep 08, 2020, 05:37 PM
Wendell Amy McBride Director Sep 03, 2020 Option Exercise $11.75 2,591 30,444 25,924 Sep 08, 2020, 05:36 PM
Levine Alan M Director Sep 03, 2020 Option Exercise $11.75 2,591 30,444 2,591 Sep 08, 2020, 05:36 PM
Blackford Quentin S. Director Sep 03, 2020 Option Exercise $11.75 2,591 30,444 18,126 Sep 08, 2020, 05:36 PM
Gold Mark Stephen Director Sep 03, 2020 Option Exercise $11.75 2,591 30,444 311,862 Sep 08, 2020, 11:05 AM
Blackford Quentin S. Director Aug 12, 2019 Buy $14.10 14,170 199,797 15,535 Jun 05, 2020, 04:48 PM
Blackford Quentin S. Director Aug 09, 2019 Buy $13.10 1,365 17,876 1,365 Jun 05, 2020, 04:48 PM
Donovan Michael Patrick VP Operations May 28, 2020 Option Exercise $4.16 15,000 62,400 43,646 Jun 01, 2020, 07:08 AM
Freitag Gregory Gene General Counsel May 29, 2020 Option Exercise $3.50 125,000 437,500 231,484 Jun 01, 2020, 07:08 AM
DeVinney Erick Wayne VP, Clinical&Translational Sc Apr 28, 2020 Option Exercise $0.27 2,530 683 51,056 Apr 29, 2020, 05:56 PM
Zaderej Karen L. CEO Apr 16, 2020 Option Exercise $4.81 11,625 55,916 658,869 Apr 20, 2020, 08:17 AM
Zaderej Karen L. CEO Feb 18, 2020 Option Exercise $14.68 5,429 79,698 631,229 Feb 20, 2020, 04:17 PM
Scopelianos Angelo VP Research & Development Feb 18, 2020 Option Exercise $14.68 394 5,784 2,249 Feb 20, 2020, 04:17 PM
MARIANI PETER J Chief Financial Officer Feb 18, 2020 Option Exercise $14.68 3,256 47,798 20,683 Feb 20, 2020, 04:16 PM
Friedman Mark Louis VP,Regulatory & Quality Feb 18, 2020 Option Exercise $14.68 924 13,564 4,802 Feb 20, 2020, 01:25 PM
Sandberg Eric Chief Commercial Officer Feb 18, 2020 Option Exercise $14.68 936 13,740 1,595 Feb 20, 2020, 01:19 PM
Freitag Gregory Gene General Counsel Feb 18, 2020 Option Exercise $14.68 1,531 22,475 106,484 Feb 20, 2020, 01:19 PM
DeVinney Erick Wayne VP, Clinical&Translational Sc Feb 18, 2020 Option Exercise $14.68 1,849 27,143 48,526 Feb 20, 2020, 01:19 PM
Billet Isabelle Chief Strategy and BD Officer Feb 18, 2020 Option Exercise $14.68 440 6,459 6,521 Feb 20, 2020, 01:18 PM
MARTINEZ MARIA D. Chief Human Resources Officer Feb 18, 2020 Option Exercise $14.68 394 5,784 2,932 Feb 20, 2020, 01:18 PM
Zaderej Karen L. CEO Jan 01, 2020 Option Exercise $17.34 10,112 175,342 622,680 Jan 17, 2020, 08:41 PM
Rudelius Robert James Director Jan 01, 2020 Option Exercise $17.89 1,999 35,762 45,592 Jan 03, 2020, 08:03 AM
Rudelius Robert James Director Jan 01, 2020 Option Exercise $2.75 13,000 35,750 47,591 Jan 03, 2020, 08:03 AM
Friedman Mark Louis VP,Regulatory & Quality Dec 18, 2019 Option Exercise $16.73 183 3,062 2,127 Dec 20, 2019, 04:27 PM
DeVinney Erick Wayne VP, Clinical&Translational Sc Dec 18, 2019 Option Exercise $16.73 281 4,701 42,840 Dec 20, 2019, 04:27 PM
MARIANI PETER J Chief Financial Officer Dec 18, 2019 Option Exercise $16.73 1,049 17,550 12,433 Dec 20, 2019, 04:27 PM
Donovan Michael Patrick VP Operations Dec 18, 2019 Option Exercise $16.73 183 3,062 26,041 Dec 20, 2019, 04:16 PM
Freitag Gregory Gene General Counsel Dec 18, 2019 Option Exercise $16.73 567 9,486 101,543 Dec 20, 2019, 04:16 PM
Donovan Michael Patrick VP Operations Oct 08, 2019 Option Exercise $4.37 6,500 28,400 25,474 Oct 10, 2019, 09:32 PM
Gold Mark Stephen Director Aug 09, 2019 Buy $13.10 4,000 52,389 348,761 Aug 15, 2019, 04:03 PM
Billet Isabelle Chief Strategy and BD Officer Aug 13, 2019 Buy $15.11 5,635 85,139 5,635 Aug 14, 2019, 04:23 PM
MARTINEZ MARIA D. Chief Human Resources Officer Aug 14, 2019 Buy $15.13 2,000 30,260 2,000 Aug 14, 2019, 04:23 PM
Blackford Quentin S. Director Aug 09, 2019 Buy $13.10 1,365 17,876 25,298 Aug 13, 2019, 08:45 AM
Blackford Quentin S. Director Aug 12, 2019 Buy $14.10 14,170 199,797 39,468 Aug 13, 2019, 08:45 AM
Zaderej Karen L. CEO Aug 09, 2019 Buy $13.50 75,000 1,012,425 593,280 Aug 12, 2019, 08:59 AM
Donovan Michael Patrick VP Operations Jun 13, 2019 Sale $20.00 20,000 400,000 18,974 Jun 14, 2019, 04:34 PM
Wendell Amy McBride Director Jun 13, 2019 Buy $20.25 5,000 101,250 23,333 Jun 14, 2019, 04:31 PM
Zaderej Karen L. CEO May 29, 2019 Option Exercise $0.27 18,056 4,875 510,280 May 31, 2019, 04:07 PM
Friedman Mark Louis VP,Regulatory & Quality May 17, 2019 Option Exercise $21.14 67,952 1,436,594 1,560 May 17, 2019, 09:47 PM
Hansen David K VP Finance & Treasurer May 13, 2019 Sale $22.63 20,000 452,600 25,588 May 16, 2019, 09:14 PM
Zaderej Karen L. CEO Feb 15, 2019 Option Exercise $17.57 16,015 281,384 492,224 Feb 19, 2019, 01:25 PM
Freitag Gregory Gene General Counsel Feb 15, 2019 Option Exercise $17.57 3,377 59,334 100,260 Feb 19, 2019, 01:25 PM
MARIANI PETER J Chief Financial Officer Feb 15, 2019 Option Exercise $17.57 2,355 41,377 9,682 Feb 19, 2019, 01:25 PM
Friedman Mark Louis VP,Regulatory & Quality Feb 15, 2019 Option Exercise $17.57 573 10,068 69,512 Feb 19, 2019, 01:25 PM
Hansen David K VP Finance & Treasurer Feb 15, 2019 Option Exercise $17.57 573 10,068 45,588 Feb 19, 2019, 01:24 PM
Donovan Michael Patrick VP Operations Feb 15, 2019 Option Exercise $17.57 573 10,068 38,974 Feb 19, 2019, 01:24 PM
DeVinney Erick Wayne VP, Clinical&Translational Sc Feb 15, 2019 Option Exercise $17.57 1,498 26,320 41,971 Feb 19, 2019, 01:24 PM
Gingrich Jon S. Chief Commercial Officer Feb 15, 2019 Option Exercise $17.57 1,342 23,579 4,190 Feb 19, 2019, 01:24 PM
Zaderej Karen L. CEO Nov 19, 2018 Option Exercise $2.74 30,000 82,200 476,209 Dec 21, 2018, 09:29 AM
Freitag Gregory Gene General Counsel Nov 30, 2018 Sale $33.00 45,000 1,485,000 95,865 Dec 04, 2018, 07:30 PM
Zaderej Karen L. CEO Nov 19, 2018 Option Exercise $28.37 6,761 191,810 446,209 Nov 21, 2018, 04:26 PM
Zaderej Karen L. CEO Nov 19, 2018 Option Exercise $2.74 70,000 191,800 452,970 Nov 21, 2018, 04:26 PM
DeVinney Erick Wayne VP, Clinical&Translational Sc Nov 13, 2018 Option Exercise $33.28 2,882 95,913 37,136 Nov 15, 2018, 05:18 PM
DeVinney Erick Wayne VP, Clinical&Translational Sc Nov 13, 2018 Option Exercise $2.72 35,274 95,974 40,018 Nov 15, 2018, 05:18 PM
Freitag Gregory Gene General Counsel Nov 15, 2018 Sale $32.25 20,000 645,000 140,865 Nov 15, 2018, 05:16 PM
Zaderej Karen L. CEO Nov 14, 2018 Sale $32.93 12,000 395,160 382,970 Nov 15, 2018, 05:14 PM
Zaderej Karen L. CEO Nov 13, 2018 Sale $33.42 13,000 434,460 394,970 Nov 15, 2018, 05:14 PM
Grooms Jamie Mark Director Sep 20, 2018 Option Exercise $2.65 12,494 33,133 18,693 Sep 24, 2018, 04:43 PM
Wendell Amy McBride Director Aug 14, 2018 Buy $36.89 5,000 184,450 18,333 Aug 16, 2018, 05:10 PM
MCCARREY SHAWN F SVP Sales Aug 07, 2018 Option Exercise $39.30 5,136 201,845 82,921 Aug 09, 2018, 04:44 PM
MCCARREY SHAWN F SVP Sales Aug 07, 2018 Option Exercise $3.67 55,000 201,850 88,057 Aug 09, 2018, 04:44 PM
Zaderej Karen L. CEO Aug 07, 2018 Option Exercise $39.30 10,060 395,358 407,970 Aug 09, 2018, 04:44 PM
Zaderej Karen L. CEO Aug 02, 2018 Option Exercise $2.74 175,000 479,500 418,030 Aug 06, 2018, 06:00 PM
Rudelius Robert James Director Jun 08, 2018 Option Exercise $48.40 682 33,009 34,591 Jun 12, 2018, 04:42 PM
Rudelius Robert James Director Jun 08, 2018 Option Exercise $2.75 12,000 33,000 35,273 Jun 12, 2018, 04:42 PM
Gold Mark Stephen Director Jun 01, 2018 Option Exercise $14.85 15,000 222,750 375,248 Jun 05, 2018, 05:02 PM
MCCARREY SHAWN F SVP Sales May 16, 2018 Sale $43.47 10,000 434,700 33,057 May 18, 2018, 06:25 PM
Donovan Michael Patrick VP Operations Mar 26, 2018 Option Exercise $40.25 2,042 82,191 37,617 Mar 27, 2018, 06:45 PM
Donovan Michael Patrick VP Operations Mar 26, 2018 Option Exercise $2.74 30,000 82,200 39,659 Mar 27, 2018, 06:45 PM
Hansen David K VP Finance & Treasurer Mar 22, 2018 Option Exercise $39.55 2,529 100,022 43,792 Mar 26, 2018, 06:13 PM
Hansen David K VP Finance & Treasurer Mar 22, 2018 Option Exercise $2.74 36,500 100,025 44,821 Mar 26, 2018, 06:13 PM
Freitag Gregory Gene General Counsel & SVP BD Mar 21, 2018 Option Exercise $38.50 2,896 111,496 160,865 Mar 23, 2018, 08:44 AM
Freitag Gregory Gene General Counsel & SVP BD Mar 21, 2018 Option Exercise $3.60 31,000 111,510 162,739 Mar 23, 2018, 08:44 AM
Freitag Gregory Gene General Counsel & SVP BD Mar 01, 2018 Option Exercise $33.95 2,905 98,625 132,761 Mar 05, 2018, 05:27 PM
Freitag Gregory Gene General Counsel & SVP BD Mar 01, 2018 Option Exercise $2.74 36,000 98,640 135,666 Mar 05, 2018, 05:27 PM
Grooms Jamie Mark Director Feb 21, 2018 Sale $28.40 57,406 1,630,330 372 Feb 23, 2018, 07:08 PM
Grooms Jamie Mark Director Feb 16, 2018 Sale $27.35 26,655 729,014 99,601 Feb 20, 2018, 07:52 PM
Grooms Jamie Mark Director Feb 20, 2018 Sale $27.90 36,740 1,025,046 62,861 Feb 20, 2018, 07:52 PM
MCCARREY SHAWN F SVP Sales Feb 16, 2018 Option Exercise $27.40 3,260 89,324 43,057 Feb 20, 2018, 07:55 AM
Grooms Jamie Mark Director Feb 13, 2018 Sale $26.21 10,300 269,924 202,595 Feb 16, 2018, 08:14 PM
Grooms Jamie Mark Director Feb 15, 2018 Sale $27.11 43,403 1,176,655 126,256 Feb 16, 2018, 08:14 PM
Grooms Jamie Mark Director Feb 14, 2018 Sale $26.72 42,009 1,122,390 169,659 Feb 16, 2018, 08:14 PM
Grooms Jamie Mark VP, CFO Feb 15, 2018 Sale $27.11 43,403 1,176,655 126,256 Feb 15, 2018, 07:56 PM
Grooms Jamie Mark VP, CFO Feb 14, 2018 Sale $26.72 42,009 1,122,390 169,659 Feb 15, 2018, 07:56 PM
Grooms Jamie Mark VP, CFO Feb 13, 2018 Sale $26.21 10,300 269,924 202,595 Feb 15, 2018, 07:56 PM
Grooms Jamie Mark Director Dec 11, 2017 Sale $26.35 21,820 574,957 257,192 Dec 13, 2017, 07:45 PM
Grooms Jamie Mark Director Dec 12, 2017 Sale $26.34 16,585 436,849 240,607 Dec 13, 2017, 07:45 PM
Grooms Jamie Mark Director Dec 08, 2017 Sale $26.37 31,805 838,698 279,012 Dec 13, 2017, 07:44 PM
Grooms Jamie Mark Director Dec 07, 2017 Sale $26.47 33,500 886,745 310,817 Dec 13, 2017, 07:44 PM
Grooms Jamie Mark Director Dec 06, 2017 Sale $26.22 21,290 558,224 344,317 Dec 13, 2017, 07:44 PM
Grooms Jamie Mark Director Dec 08, 2017 Sale $26.37 31,805 838,698 281,312 Dec 08, 2017, 06:30 PM
Grooms Jamie Mark Director Dec 07, 2017 Sale $26.50 31,200 826,800 313,117 Dec 08, 2017, 06:30 PM
Grooms Jamie Mark Director Dec 06, 2017 Sale $26.22 21,290 558,224 344,317 Dec 08, 2017, 06:30 PM
Essex Woodlands Fund IX, L.P. 10% Owner Nov 20, 2017 Sale $19.74 1,150,000 22,701,000 3,711,111 Nov 21, 2017, 03:31 PM
NEELS GUIDO J Director Nov 20, 2017 Sale $19.74 1,150,000 22,701,000 3,371,111 Nov 21, 2017, 03:31 PM
Gold Mark Stephen Director Nov 13, 2017 Option Exercise $5.09 15,000 76,350 360,248 Nov 15, 2017, 11:22 AM
Grooms Jamie Mark Director Nov 01, 2017 Option Exercise $20.60 189 3,893 365,607 Nov 03, 2017, 04:56 PM
Grooms Jamie Mark Director Nov 01, 2017 Option Exercise $0.27 14,379 3,882 365,796 Nov 03, 2017, 04:56 PM
Friedman Mark Louis VP,Regulatory & Quality Oct 24, 2017 Option Exercise $20.00 5,480 109,600 40,185 Oct 26, 2017, 05:04 PM
Friedman Mark Louis VP,Regulatory & Quality Oct 24, 2017 Option Exercise $2.58 67,767 174,962 67,952 Oct 26, 2017, 05:04 PM
Freitag Gregory Gene General Counsel & SVP BD Sep 25, 2017 Option Exercise $18.90 1,450 27,405 99,666 Sep 27, 2017, 05:22 PM
Freitag Gregory Gene General Counsel & SVP BD Sep 25, 2017 Option Exercise $2.74 10,000 27,400 101,116 Sep 27, 2017, 05:22 PM
Rudelius Robert James Director Sep 08, 2017 Option Exercise $18.15 3,857 70,005 39,416 Sep 12, 2017, 04:02 PM
Rudelius Robert James Director Sep 08, 2017 Option Exercise $3.50 20,000 70,000 43,273 Sep 12, 2017, 04:02 PM
Rudelius Robert James Director Sep 11, 2017 Sale $18.00 16,143 290,574 23,273 Sep 12, 2017, 04:02 PM
Freitag Gregory Gene General Counsel & SVP BD Aug 27, 2017 Option Exercise $16.65 3,785 63,020 91,116 Aug 29, 2017, 04:58 PM
Freitag Gregory Gene General Counsel & SVP BD Aug 27, 2017 Option Exercise $2.74 23,000 63,020 94,901 Aug 29, 2017, 04:58 PM
MCCARREY SHAWN F SVP Sales Aug 02, 2017 Option Exercise $15.15 2,383 36,102 39,167 Aug 04, 2017, 05:10 PM
Gold Mark Stephen Director May 30, 2017 Option Exercise $8.95 5,000 44,750 345,248 Jun 01, 2017, 01:51 PM
Gold Mark Stephen Director May 22, 2017 Option Exercise $4.81 15,000 72,150 340,248 May 26, 2017, 04:24 PM
DeVinney Erick Wayne VP, Clinical&Translational Sc Mar 14, 2017 Option Exercise $0.27 5,018 1,355 5,018 Mar 14, 2017, 07:32 PM
Donovan Michael Patrick VP Operations Mar 14, 2017 Option Exercise $1.55 9,659 14,958 9,659 Mar 14, 2017, 07:32 PM
Freitag Gregory Gene General Counsel & SVP BD Dec 30, 2016 Option Exercise $2.74 23,000 63,020 71,901 Mar 14, 2017, 07:31 PM
Wendell Amy McBride Director Oct 07, 2016 Buy $7.50 13,333 99,998 13,333 Oct 14, 2016, 03:36 PM
Leach Kevin Vice President Marketing Oct 07, 2016 Buy $7.50 2,000 15,000 2,000 Oct 14, 2016, 03:14 PM
MARIANI PETER J Chief Financial Officer Oct 07, 2016 Buy $7.50 3,333 24,998 3,333 Oct 14, 2016, 03:13 PM
Zaderej Karen L. CEO Oct 07, 2016 Buy $7.50 10,000 75,000 242,147 Oct 14, 2016, 01:37 PM
Engels John P VP Oct 07, 2016 Buy $7.50 4,000 30,000 98,425 Oct 14, 2016, 01:37 PM
Gold Mark Stephen Director Aug 17, 2016 Option Exercise $3.60 3,750 13,500 325,248 Aug 19, 2016, 03:25 PM
Mandato Joseph M Director Aug 09, 2016 Sale $8.30 42,168 349,994 1,226,773 Aug 10, 2016, 07:28 PM
Mandato Joseph M Director Aug 08, 2016 Sale $8.63 107,450 927,294 1,268,941 Aug 10, 2016, 07:28 PM
Flynn James E 10% Owner Jul 21, 2016 Sale $6.70 102,136 684,311 3,000,000 Jul 21, 2016, 04:26 PM
Flynn James E 10% Owner Jul 18, 2016 Sale $6.87 41,425 284,590 3,102,136 Jul 18, 2016, 06:20 PM
Flynn James E 10% Owner Jul 15, 2016 Sale $7.32 31,788 232,688 3,143,561 Jul 18, 2016, 06:20 PM
Flynn James E 10% Owner Jul 14, 2016 Sale $7.70 206,090 1,586,893 3,175,349 Jul 18, 2016, 06:20 PM
Hansen David K Chief Accounting Officer May 31, 2016 Option Exercise $0.27 9,821 2,652 9,821 Jun 01, 2016, 05:00 PM
Gold Mark Stephen Director Nov 12, 2015 Option Exercise $3.60 11,250 40,500 321,498 Nov 12, 2015, 06:55 PM
Gold Mark Stephen Director Nov 06, 2015 Sale $5.70 6,013 34,274 310,248 Nov 12, 2015, 09:24 AM
Flynn James E 10% Owner Sep 18, 2015 Sale $5.50 345,000 1,897,983 3,381,439 Sep 22, 2015, 01:05 PM
Gold Mark Stephen Director Sep 08, 2015 Option Exercise $2.75 13,000 35,750 316,261 Sep 10, 2015, 03:41 PM
Mandato Joseph M Director Jun 03, 2015 Buy $3.10 6,500 20,150 50,000 Jun 05, 2015, 03:14 PM
Johnston Lee Robert Jr Chief Finacial Officer Jun 02, 2015 Buy $3.06 5,000 15,303 25,000 Jun 03, 2015, 04:46 PM
Zaderej Karen L. Chief Executive Officer May 27, 2015 Buy $3.16 3,325 10,493 232,147 May 29, 2015, 02:58 PM
Flynn James E 10% Owner Apr 08, 2015 Sale $3.25 144,385 469,251 3,726,439 Apr 09, 2015, 01:55 PM
Gold Mark Stephen Director Sep 30, 2014 Option Exercise $1.07 290 310 303,261 Mar 12, 2015, 09:21 AM
Zaderej Karen L. Chief Executive Officer Feb 10, 2015 Option Exercise $2.75 9,600 26,400 228,822 Feb 12, 2015, 03:44 PM
Freitag Gregory Gene General Counsel Feb 10, 2015 Option Exercise $2.75 4,800 13,200 48,902 Feb 12, 2015, 03:44 PM
MCCARREY SHAWN F SVP of Sales Feb 10, 2015 Option Exercise $2.75 4,400 12,100 34,400 Feb 12, 2015, 03:43 PM
Mandato Joseph M Director Dec 11, 2014 Sale $3.15 2,342 7,377 1,376,392 Jan 06, 2015, 06:25 PM
Mandato Joseph M Director Dec 10, 2014 Sale $3.06 47,658 145,714 1,378,734 Jan 06, 2015, 06:25 PM
Johnston Lee Robert Jr Chief Financial Officer Dec 10, 2014 Buy $3.06 10,000 30,600 10,000 Dec 11, 2014, 03:39 PM
Mandato Joseph M Director Dec 01, 2014 Option Exercise $2.94 6,000 17,640 43,500 Dec 03, 2014, 09:57 PM
Gold Mark Stephen Director Sep 30, 2014 Option Exercise $1.07 290 310 303,261 Oct 02, 2014, 06:08 PM
Gold Mark Stephen Director Aug 12, 2014 Buy $2.29 20,000 45,800 302,971 Aug 15, 2014, 07:44 AM
Mandato Joseph M Director Aug 08, 2014 Option Exercise $2.30 7,500 17,275 37,500 Aug 12, 2014, 05:00 PM
Gold Mark Stephen Director Aug 08, 2014 Buy $2.31 11,000 25,410 282,971 Aug 11, 2014, 01:15 PM
Johnston Lee Robert Jr Chief Financial Officer Jun 06, 2014 Buy $2.58 10,000 25,757 10,000 Jun 10, 2014, 05:15 PM
Zaderej Karen L. Chief Executive Officer Jun 03, 2014 Buy $2.43 5,000 12,150 334,056 Jun 04, 2014, 03:54 PM
Freitag Gregory Gene CFO Jun 03, 2014 Buy $2.34 200 468 29,518 Jun 04, 2014, 03:53 PM
Freitag Gregory Gene CFO Jun 02, 2014 Buy $2.45 5,000 12,250 29,318 Jun 04, 2014, 03:53 PM
Schiaparelli Jill F SVP, Bus. Strategy&Marketing May 20, 2014 Buy $2.63 2,000 5,260 12,750 May 22, 2014, 05:56 PM
Zaderej Karen L. Chief Executive Officer May 12, 2014 Buy $2.70 5,000 13,500 329,056 May 13, 2014, 10:55 AM
Mandato Joseph M Director May 05, 2014 Option Exercise $2.64 15,000 39,600 30,000 May 12, 2014, 12:33 PM
Gold Mark Stephen Director May 07, 2014 Buy $2.60 1,487 3,866 271,971 May 08, 2014, 05:20 PM
Gold Mark Stephen Director May 06, 2014 Buy $2.60 490 1,274 270,484 May 08, 2014, 05:20 PM
Gold Mark Stephen Director Apr 25, 2014 Option Exercise $2.02 17,007 34,352 269,994 Apr 28, 2014, 05:35 PM
Zaderej Karen L. Chief Executive Officer Mar 14, 2014 Option Exercise $0.27 72,348 19,534 209,222 Mar 17, 2014, 07:34 PM
Zaderej Karen L. Chief Executive Officer Mar 13, 2014 Buy $3.49 1,500 5,233 136,874 Mar 17, 2014, 07:34 PM
Gold Mark Stephen Director Nov 19, 2013 Option Exercise $1.07 290 311 252,987 Nov 19, 2013, 02:43 PM
MCCARREY SHAWN F SVP of Sales Aug 29, 2013 Buy $3.21 12,625 40,526 30,000 Aug 30, 2013, 01:47 PM
MCCARREY SHAWN F SVP of Sales Aug 28, 2013 Buy $3.20 12,375 39,625 17,375 Aug 30, 2013, 01:47 PM
MCCARREY SHAWN F SVP of Sales Aug 24, 2013 Buy $3.00 5,000 15,000 5,000 Aug 27, 2013, 01:24 PM
Mandato Joseph M Director Aug 19, 2013 Option Exercise $3.00 10,000 30,000 15,000 Aug 20, 2013, 06:19 PM
Mandato Joseph M Director Aug 16, 2013 Option Exercise $2.99 5,000 14,950 5,000 Aug 20, 2013, 06:19 PM
Schiaparelli Jill F SVP, Bus. Strategy&Marketing Aug 14, 2013 Buy $3.00 5,000 15,000 10,750 Aug 16, 2013, 02:48 PM
Harper John Frederick Director Aug 14, 2013 Buy $3.00 66,666 199,998 214,094 Aug 15, 2013, 03:45 PM
Zaderej Karen L. Chief Executive Officer Aug 14, 2013 Buy $3.00 8,334 25,002 129,124 Aug 15, 2013, 03:18 PM
Freitag Gregory Gene CFO Aug 14, 2013 Buy $3.00 8,334 25,002 32,652 Aug 15, 2013, 03:07 PM
Harper John Frederick Director Oct 01, 2012 Buy $3.61 86,557 312,471 147,428 Apr 10, 2013, 04:34 PM
Gold Mark Stephen Director Feb 25, 2013 Option Exercise $0.31 5,296 1,662 19,484 Feb 28, 2013, 02:32 PM
Gold Mark Stephen Director May 10, 2012 Option Exercise $0.27 8,733 2,358 14,188 Feb 28, 2013, 02:32 PM
Zaderej Karen L. Chief Executive Officer Dec 10, 2012 Buy $2.50 900 2,250 120,790 Dec 13, 2012, 01:25 PM
Schiaparelli Jill F SVP, Bus. Strategy&Marketing Dec 04, 2012 Buy $2.55 2,000 5,100 5,750 Dec 06, 2012, 08:20 AM
Schiaparelli Jill F SVP, Bus. Strategy&Marketing Nov 29, 2012 Buy $2.70 1,000 2,700 3,750 Dec 03, 2012, 04:08 PM
Zaderej Karen L. Chief Executive Officer Nov 20, 2012 Buy $2.69 100 269 119,890 Nov 23, 2012, 09:18 AM
Schiaparelli Jill F SVP, Bus. Strategy&Marketing Nov 15, 2012 Buy $2.52 2,000 5,040 1,000 Nov 16, 2012, 03:26 PM
Schiaparelli Jill F SVP, Bus. Strategy&Marketing Nov 14, 2012 Buy $2.66 750 1,995 750 Nov 16, 2012, 03:26 PM
Mandato Joseph M Director Oct 10, 2011 Option Exercise $2.75 5,455 15,001 1,431,847 Feb 13, 2012, 02:14 PM
Friedman Mark Louis Vice President of RA/QA Dec 23, 2011 Option Exercise $0.27 5,665 1,530 5,665 Jan 24, 2012, 04:08 PM
Rudelius Robert James Director Dec 30, 2011 Option Exercise $2.40 9,318 22,363 23,273 Jan 03, 2012, 03:50 PM
Freitag Gregory Gene CFO Dec 30, 2011 Buy $2.40 9,318 22,363 24,318 Jan 03, 2012, 03:49 PM
Zaderej Karen L. Chief Executive Officer Dec 19, 2011 Option Exercise $0.27 76,741 20,720 119,790 Dec 21, 2011, 08:18 PM
Rudelius Robert James Director Nov 05, 2011 Buy $2.70 3,500 9,450 13,955 Dec 06, 2011, 07:51 AM
Rudelius Robert James Director Nov 02, 2011 Buy $2.74 4,500 12,325 10,455 Dec 06, 2011, 07:51 AM
Rudelius Robert James Director Nov 01, 2011 Buy $2.70 500 1,350 5,955 Dec 06, 2011, 07:51 AM
Freitag Gregory Gene CFO Nov 22, 2011 Buy $2.92 9,000 26,250 15,000 Nov 23, 2011, 02:36 PM
Freitag Gregory Gene CFO Nov 21, 2011 Buy $2.90 6,000 17,395 6,000 Nov 23, 2011, 02:36 PM
Grooms Jamie Mark Director Oct 10, 2011 Option Exercise $2.75 5,455 15,001 218,534 Oct 12, 2011, 05:35 PM
Rudelius Robert James Director Oct 10, 2011 Option Exercise $2.75 5,455 15,001 5,455 Oct 12, 2011, 05:33 PM
Harper John Frederick Director Oct 10, 2011 Option Exercise $2.75 5,455 15,001 51,553 Oct 12, 2011, 05:31 PM
Mandato Joseph M Director Oct 10, 2011 Option Exercise $2.75 5,455 15,001 5,455 Oct 12, 2011, 05:27 PM
Gold Mark Stephen Director Oct 10, 2011 Option Exercise $2.75 5,455 15,001 5,455 Oct 12, 2011, 05:25 PM
Hopfenspirger Larry 10% Owner Sep 28, 2011 Buy $1.81 20,000 36,200 426,066 Sep 28, 2011, 05:29 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Zaderej Karen L. CEO 11/24/2021 468,756
Zaderej Karen L. CEO 08/12/2021 42,013
Zaderej Karen L. CEO 08/13/2021 170,655
Zaderej Karen L. CEO 08/10/2021 381,750
Zaderej Karen L. CEO 08/06/2021 757,194
Donovan Michael Patrick VP Operations 07/21/2021 38,777
DeVinney Erick Wayne VP Peripheral Nerve Science 07/20/2021 7,526
Donovan Michael Patrick VP Operations 07/20/2021 12,230
Zaderej Karen L. CEO 07/20/2021 169,190
Sandberg Eric Chief Commercial Officer 07/20/2021 20,928
Scopelianos Angelo Chief R&D Officer 07/20/2021 12,230
MARIANI PETER J EVP & Chief Financial Officer 07/20/2021 17,626
Billet Isabelle Chief Strategy and BD Officer 07/20/2021 13,978
MARTINEZ MARIA D. Chief Human Resources Officer 07/20/2021 12,230
Friedman Mark Louis VP Regulatory Affairs & Policy 07/20/2021 12,230
NEELS GUIDO J Director 05/19/2021 171,350
DeVinney Erick Wayne VP of Clin. & Trans. Sciences 04/28/2021 28,600
Zaderej Karen L. CEO 04/16/2021 509,000
Zaderej Karen L. CEO 03/25/2021 126,615
Freitag Gregory Gene Director 02/25/2021 529,440
Donovan Michael Patrick VP Operations 02/18/2021 34,623
Scopelianos Angelo Chief R&D Officer 02/17/2021 7,596
Friedman Mark Louis VP, Regulatory & Quality 02/17/2021 17,787
DeVinney Erick Wayne VP, Clinical&Translational Sc 02/17/2021 34,857
Sandberg Eric Chief Commercial Officer 02/17/2021 16,886
Donovan Michael Patrick VP Operations 02/17/2021 14,912
Freitag Gregory Gene Director 02/17/2021 29,490
MARTINEZ MARIA D. Chief Human Resources Officer 02/17/2021 7,596
MARIANI PETER J Chief Financial Officer 02/17/2021 55,261
Zaderej Karen L. CEO 02/17/2021 143,805
Billet Isabelle Chief Strategy and BD Officer 02/17/2021 8,494
Donovan Michael Patrick VP Operations 02/05/2021 102,814
Donovan Michael Patrick VP Operations 02/05/2021 102,800
Zaderej Karen L. CEO 01/08/2021 1,300,000
Donovan Michael Patrick VP Operations 12/30/2020 30,293
DeVinney Erick Wayne VP, Clinical&Translational Sc 12/29/2020 6,608
Donovan Michael Patrick VP Operations 12/29/2020 10,098
Freitag Gregory Gene Director 12/29/2020 16,314
MARIANI PETER J Chief Financial Officer 12/29/2020 23,028
Scopelianos Angelo VP Research & Development 12/29/2020 10,098
Zaderej Karen L. CEO 12/29/2020 62,335
Friedman Mark Louis VP,Regulatory & Quality 12/29/2020 10,098
MARTINEZ MARIA D. Chief Human Resources Officer 12/29/2020 10,098
Billet Isabelle Chief Strategy and BD Officer 12/29/2020 11,559
Zaderej Karen L. CEO 12/23/2020 93,194
Donovan Michael Patrick VP Operations 12/22/2020 4,796
Zaderej Karen L. CEO 12/21/2020 20,936
DeVinney Erick Wayne VP, Clinical&Translational Sc 12/21/2020 2,414
Freitag Gregory Gene Director 12/21/2020 6,223
Donovan Michael Patrick VP Operations 12/21/2020 1,576
MARIANI PETER J Chief Financial Officer 12/21/2020 7,898
Friedman Mark Louis VP,Regulatory & Quality 12/21/2020 1,576
DeVinney Erick Wayne VP, Clinical&Translational Sc 12/15/2020 72,155
DeVinney Erick Wayne VP, Clinical&Translational Sc 12/15/2020 72,150
Friedman Mark Louis VP,Regulatory & Quality 12/03/2020 14,703
Donovan Michael Patrick VP Operations 11/09/2020 264,255
Zaderej Karen L. CEO 11/09/2020 203,420
MARIANI PETER J Chief Financial Officer 10/30/2020 302,400
MARIANI PETER J Chief Financial Officer 10/30/2020 939,353
Freitag Gregory Gene Director 09/15/2020 47,879
NEELS GUIDO J Director 09/03/2020 30,444
Rudelius Robert James Director 09/03/2020 30,444
Wendell Amy McBride Director 09/03/2020 30,444
Levine Alan M Director 09/03/2020 30,444
Blackford Quentin S. Director 09/03/2020 30,444
Gold Mark Stephen Director 09/03/2020 30,444
Blackford Quentin S. Director 08/12/2019 199,797
Blackford Quentin S. Director 08/09/2019 17,876
Donovan Michael Patrick VP Operations 05/28/2020 62,400
Freitag Gregory Gene General Counsel 05/29/2020 437,500
DeVinney Erick Wayne VP, Clinical&Translational Sc 04/28/2020 683
Zaderej Karen L. CEO 04/16/2020 55,916
Zaderej Karen L. CEO 02/18/2020 79,698
Scopelianos Angelo VP Research & Development 02/18/2020 5,784
MARIANI PETER J Chief Financial Officer 02/18/2020 47,798
Friedman Mark Louis VP,Regulatory & Quality 02/18/2020 13,564
Sandberg Eric Chief Commercial Officer 02/18/2020 13,740
Freitag Gregory Gene General Counsel 02/18/2020 22,475
DeVinney Erick Wayne VP, Clinical&Translational Sc 02/18/2020 27,143
Billet Isabelle Chief Strategy and BD Officer 02/18/2020 6,459
MARTINEZ MARIA D. Chief Human Resources Officer 02/18/2020 5,784
Zaderej Karen L. CEO 01/01/2020 175,342
Rudelius Robert James Director 01/01/2020 35,762
Rudelius Robert James Director 01/01/2020 35,750
Friedman Mark Louis VP,Regulatory & Quality 12/18/2019 3,062
DeVinney Erick Wayne VP, Clinical&Translational Sc 12/18/2019 4,701
MARIANI PETER J Chief Financial Officer 12/18/2019 17,550
Donovan Michael Patrick VP Operations 12/18/2019 3,062
Freitag Gregory Gene General Counsel 12/18/2019 9,486
Donovan Michael Patrick VP Operations 10/08/2019 28,400
Gold Mark Stephen Director 08/09/2019 52,389
Billet Isabelle Chief Strategy and BD Officer 08/13/2019 85,139
MARTINEZ MARIA D. Chief Human Resources Officer 08/14/2019 30,260
Blackford Quentin S. Director 08/09/2019 17,876
Blackford Quentin S. Director 08/12/2019 199,797
Zaderej Karen L. CEO 08/09/2019 1,012,425
Donovan Michael Patrick VP Operations 06/13/2019 400,000
Wendell Amy McBride Director 06/13/2019 101,250
Zaderej Karen L. CEO 05/29/2019 4,875
Friedman Mark Louis VP,Regulatory & Quality 05/17/2019 1,436,594
Hansen David K VP Finance & Treasurer 05/13/2019 452,600
Zaderej Karen L. CEO 02/15/2019 281,384
Freitag Gregory Gene General Counsel 02/15/2019 59,334
MARIANI PETER J Chief Financial Officer 02/15/2019 41,377
Friedman Mark Louis VP,Regulatory & Quality 02/15/2019 10,068
Hansen David K VP Finance & Treasurer 02/15/2019 10,068
Donovan Michael Patrick VP Operations 02/15/2019 10,068
DeVinney Erick Wayne VP, Clinical&Translational Sc 02/15/2019 26,320
Gingrich Jon S. Chief Commercial Officer 02/15/2019 23,579
Zaderej Karen L. CEO 11/19/2018 82,200
Freitag Gregory Gene General Counsel 11/30/2018 1,485,000
Zaderej Karen L. CEO 11/19/2018 191,810
Zaderej Karen L. CEO 11/19/2018 191,800
DeVinney Erick Wayne VP, Clinical&Translational Sc 11/13/2018 95,913
DeVinney Erick Wayne VP, Clinical&Translational Sc 11/13/2018 95,974
Freitag Gregory Gene General Counsel 11/15/2018 645,000
Zaderej Karen L. CEO 11/14/2018 395,160
Zaderej Karen L. CEO 11/13/2018 434,460
Grooms Jamie Mark Director 09/20/2018 33,133
Wendell Amy McBride Director 08/14/2018 184,450
MCCARREY SHAWN F SVP Sales 08/07/2018 201,845
MCCARREY SHAWN F SVP Sales 08/07/2018 201,850
Zaderej Karen L. CEO 08/07/2018 395,358
Zaderej Karen L. CEO 08/02/2018 479,500
Rudelius Robert James Director 06/08/2018 33,009
Rudelius Robert James Director 06/08/2018 33,000
Gold Mark Stephen Director 06/01/2018 222,750
MCCARREY SHAWN F SVP Sales 05/16/2018 434,700
Donovan Michael Patrick VP Operations 03/26/2018 82,191
Donovan Michael Patrick VP Operations 03/26/2018 82,200
Hansen David K VP Finance & Treasurer 03/22/2018 100,022
Hansen David K VP Finance & Treasurer 03/22/2018 100,025
Freitag Gregory Gene General Counsel & SVP BD 03/21/2018 111,496
Freitag Gregory Gene General Counsel & SVP BD 03/21/2018 111,510
Freitag Gregory Gene General Counsel & SVP BD 03/01/2018 98,625
Freitag Gregory Gene General Counsel & SVP BD 03/01/2018 98,640
Grooms Jamie Mark Director 02/21/2018 1,630,330
Grooms Jamie Mark Director 02/16/2018 729,014
Grooms Jamie Mark Director 02/20/2018 1,025,046
MCCARREY SHAWN F SVP Sales 02/16/2018 89,324
Grooms Jamie Mark Director 02/13/2018 269,924
Grooms Jamie Mark Director 02/15/2018 1,176,655
Grooms Jamie Mark Director 02/14/2018 1,122,390
Grooms Jamie Mark VP, CFO 02/15/2018 1,176,655
Grooms Jamie Mark VP, CFO 02/14/2018 1,122,390
Grooms Jamie Mark VP, CFO 02/13/2018 269,924
Grooms Jamie Mark Director 12/11/2017 574,957
Grooms Jamie Mark Director 12/12/2017 436,849
Grooms Jamie Mark Director 12/08/2017 838,698
Grooms Jamie Mark Director 12/07/2017 886,745
Grooms Jamie Mark Director 12/06/2017 558,224
Grooms Jamie Mark Director 12/08/2017 838,698
Grooms Jamie Mark Director 12/07/2017 826,800
Grooms Jamie Mark Director 12/06/2017 558,224
Essex Woodlands Fund IX, L.P. 10% Owner 11/20/2017 22,701,000
NEELS GUIDO J Director 11/20/2017 22,701,000
Gold Mark Stephen Director 11/13/2017 76,350
Grooms Jamie Mark Director 11/01/2017 3,893
Grooms Jamie Mark Director 11/01/2017 3,882
Friedman Mark Louis VP,Regulatory & Quality 10/24/2017 109,600
Friedman Mark Louis VP,Regulatory & Quality 10/24/2017 174,962
Freitag Gregory Gene General Counsel & SVP BD 09/25/2017 27,405
Freitag Gregory Gene General Counsel & SVP BD 09/25/2017 27,400
Rudelius Robert James Director 09/08/2017 70,005
Rudelius Robert James Director 09/08/2017 70,000
Rudelius Robert James Director 09/11/2017 290,574
Freitag Gregory Gene General Counsel & SVP BD 08/27/2017 63,020
Freitag Gregory Gene General Counsel & SVP BD 08/27/2017 63,020
MCCARREY SHAWN F SVP Sales 08/02/2017 36,102
Gold Mark Stephen Director 05/30/2017 44,750
Gold Mark Stephen Director 05/22/2017 72,150
DeVinney Erick Wayne VP, Clinical&Translational Sc 03/14/2017 1,355
Donovan Michael Patrick VP Operations 03/14/2017 14,958
Freitag Gregory Gene General Counsel & SVP BD 12/30/2016 63,020
Wendell Amy McBride Director 10/07/2016 99,998
Leach Kevin Vice President Marketing 10/07/2016 15,000
MARIANI PETER J Chief Financial Officer 10/07/2016 24,998
Zaderej Karen L. CEO 10/07/2016 75,000
Engels John P VP 10/07/2016 30,000
Gold Mark Stephen Director 08/17/2016 13,500
Mandato Joseph M Director 08/09/2016 349,994
Mandato Joseph M Director 08/08/2016 927,294
Flynn James E 10% Owner 07/21/2016 684,311
Flynn James E 10% Owner 07/18/2016 284,590
Flynn James E 10% Owner 07/15/2016 232,688
Flynn James E 10% Owner 07/14/2016 1,586,893
Hansen David K Chief Accounting Officer 05/31/2016 2,652
Gold Mark Stephen Director 11/12/2015 40,500
Gold Mark Stephen Director 11/06/2015 34,274
Flynn James E 10% Owner 09/18/2015 1,897,983
Gold Mark Stephen Director 09/08/2015 35,750
Mandato Joseph M Director 06/03/2015 20,150
Johnston Lee Robert Jr Chief Finacial Officer 06/02/2015 15,303
Zaderej Karen L. Chief Executive Officer 05/27/2015 10,493
Flynn James E 10% Owner 04/08/2015 469,251
Gold Mark Stephen Director 09/30/2014 310
Zaderej Karen L. Chief Executive Officer 02/10/2015 26,400
Freitag Gregory Gene General Counsel 02/10/2015 13,200
MCCARREY SHAWN F SVP of Sales 02/10/2015 12,100
Mandato Joseph M Director 12/11/2014 7,377
Mandato Joseph M Director 12/10/2014 145,714
Johnston Lee Robert Jr Chief Financial Officer 12/10/2014 30,600
Mandato Joseph M Director 12/01/2014 17,640
Gold Mark Stephen Director 09/30/2014 310
Gold Mark Stephen Director 08/12/2014 45,800
Mandato Joseph M Director 08/08/2014 17,275
Gold Mark Stephen Director 08/08/2014 25,410
Johnston Lee Robert Jr Chief Financial Officer 06/06/2014 25,757
Zaderej Karen L. Chief Executive Officer 06/03/2014 12,150
Freitag Gregory Gene CFO 06/03/2014 468
Freitag Gregory Gene CFO 06/02/2014 12,250
Schiaparelli Jill F SVP, Bus. Strategy&Marketing 05/20/2014 5,260
Zaderej Karen L. Chief Executive Officer 05/12/2014 13,500
Mandato Joseph M Director 05/05/2014 39,600
Gold Mark Stephen Director 05/07/2014 3,866
Gold Mark Stephen Director 05/06/2014 1,274
Gold Mark Stephen Director 04/25/2014 34,352
Zaderej Karen L. Chief Executive Officer 03/14/2014 19,534
Zaderej Karen L. Chief Executive Officer 03/13/2014 5,233
Gold Mark Stephen Director 11/19/2013 311
MCCARREY SHAWN F SVP of Sales 08/29/2013 40,526
MCCARREY SHAWN F SVP of Sales 08/28/2013 39,625
MCCARREY SHAWN F SVP of Sales 08/24/2013 15,000
Mandato Joseph M Director 08/19/2013 30,000
Mandato Joseph M Director 08/16/2013 14,950
Schiaparelli Jill F SVP, Bus. Strategy&Marketing 08/14/2013 15,000
Harper John Frederick Director 08/14/2013 199,998
Zaderej Karen L. Chief Executive Officer 08/14/2013 25,002
Freitag Gregory Gene CFO 08/14/2013 25,002
Harper John Frederick Director 10/01/2012 312,471
Gold Mark Stephen Director 02/25/2013 1,662
Gold Mark Stephen Director 05/10/2012 2,358
Zaderej Karen L. Chief Executive Officer 12/10/2012 2,250
Schiaparelli Jill F SVP, Bus. Strategy&Marketing 12/04/2012 5,100
Schiaparelli Jill F SVP, Bus. Strategy&Marketing 11/29/2012 2,700
Zaderej Karen L. Chief Executive Officer 11/20/2012 269
Schiaparelli Jill F SVP, Bus. Strategy&Marketing 11/15/2012 5,040
Schiaparelli Jill F SVP, Bus. Strategy&Marketing 11/14/2012 1,995
Mandato Joseph M Director 10/10/2011 15,001
Friedman Mark Louis Vice President of RA/QA 12/23/2011 1,530
Rudelius Robert James Director 12/30/2011 22,363
Freitag Gregory Gene CFO 12/30/2011 22,363
Zaderej Karen L. Chief Executive Officer 12/19/2011 20,720
Rudelius Robert James Director 11/05/2011 9,450
Rudelius Robert James Director 11/02/2011 12,325
Rudelius Robert James Director 11/01/2011 1,350
Freitag Gregory Gene CFO 11/22/2011 26,250
Freitag Gregory Gene CFO 11/21/2011 17,395
Grooms Jamie Mark Director 10/10/2011 15,001
Rudelius Robert James Director 10/10/2011 15,001
Harper John Frederick Director 10/10/2011 15,001
Mandato Joseph M Director 10/10/2011 15,001
Gold Mark Stephen Director 10/10/2011 15,001
Hopfenspirger Larry 10% Owner 09/28/2011 36,200
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
06/30/2021
03/31/2021
0.46%
1Q
06/30/2021
12/31/2020
2.32%
2Q
06/30/2021
09/30/2020
2.56%
3Q
06/30/2021
03/31/2020
3.01%
5Q
06/30/2021
09/30/2019
4.45%
7Q
06/30/2021
03/31/2019
5.04%
9Q
06/30/2021
12/31/2018
10.15%
10Q
06/30/2021
09/30/2018
11.79%
11Q
06/30/2021
03/31/2018
18.46%
13Q
06/30/2021
12/31/2017
22.72%
14Q
06/30/2021
09/30/2017
23.37%
15Q
06/30/2021
06/30/2017
23.64%
16Q
Load More

Period of Report: 06/30/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
03/31/2021
0.46%
1Q
12/31/2020
2.32%
2Q
09/30/2020
2.56%
3Q
03/31/2020
3.01%
5Q
09/30/2019
4.45%
7Q
03/31/2019
5.04%
9Q
12/31/2018
10.15%
10Q
09/30/2018
11.79%
11Q
03/31/2018
18.46%
13Q
12/31/2017
22.72%
14Q
09/30/2017
23.37%
15Q
06/30/2017
23.64%
16Q
Load More